Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study
Titel:
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study
Auteur:
Han, H.S. Diéras, V. Robson, M. Palácová, M. Marcom, P.K. Jager, A. Bondarenko, I. Citrin, D. Campone, M. Telli, M.L. Domchek, S.M. Friedlander, M. Kaufman, B. Garber, J.E. Shparyk, Y. Chmielowska, E. Jakobsen, E.H. Kaklamani, V. Gradishar, W. Ratajczak, C.K. Nickner, C. Qin, Q. Qian, J. Shepherd, S.P. Isakoff, S.J. Puhalla, S.